Results 41 to 50 of about 10,082 (250)

Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study [PDF]

open access: yes, 2011
Background Vinblastine (VBL) is the standard treatment for systemic Langerhans cell histiocytosis (LCH), but little is known about its efficacy in central nervous system (CNS) mass lesions. Methods
Sophie Ng Wing Tin   +30 more
core   +2 more sources

Indeterminate Cell Histiocytosis: A Case Report

open access: yesKaohsiung Journal of Medical Sciences, 2004
Indeterminate cell histiocytosis is a rare neoplasm composed of cells with mixed characteristics of Langerhans cells and non-Langerhans cells. An otherwise healthy, 36-year-old woman presented with asymptomatic generalized papules and nodules that had ...
Chun-Hua Wang, Gwo-Shing Chen
doaj   +1 more source

ADULT ONSET XANTHOGRANULOMA – CASE REPORT AND REVIEW OF LITERATURE [PDF]

open access: yesRomanian Medical Journal, 2019
Juvenile xanthogranuloma represents the most common form of non-Langerhans cell histiocytosis. It is tipically a childhood disorder, over 80% of cases developing in the first year of life.
Liliana Gabriela Popa   +5 more
doaj   +1 more source

Langerhans cell histiocytosis [PDF]

open access: yes, 1998
The authors present a rare case of Langerhans cell histiocytosis in a 31 year old female patient with vulvar, peri-anal and oral lesions, diabetes insipidus, pulmonary skin and bone infiltrations.
Atallah, Álvaro Nagib   +10 more
core   +2 more sources

Unusual facial lesions in H syndrome

open access: yesClinical Case Reports, 2022
H Syndrome is a rare genodermatosis. It may include facial involvement such as: facial telangiectasia, both hypo‐ and hyperpigmented lesions, hirsutism, swollen cheeks due to subcutaneous infiltration and eczematous lesions.
Mariem Rekik   +7 more
doaj   +1 more source

Erdheim-Chester Disease: a comprehensive review of the literature [PDF]

open access: yes, 2013
Erdheim-Chester Disease (ECD) is a rare form of non Langerhans' cell histiocytosis. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. Males and females are almost equally affected.
Mirra Manevich-Mazor   +2 more
core   +1 more source

Clinical experience in an infant with Langerhans cell histiocytosis

open access: yesUniversidad Médica Pinareña, 2021
Introduction: Langerhans cell histiocytosis (LCH) or Histiocytosis X is a benign proliferative disease affecting dendritic cells. It presents a wide clinical spectrum, from isolated eosinophilic bone granuloma to multisystem involvement with multiple ...
Yamilka Pita Barrios   +2 more
doaj  

Cutaneous Rosai-Dorfman Disease - A Rare Non-Langerhans Cell Histiocytosis

open access: yesJK Science
Cutaneous Rosai-Dorfman disease is classified as non-Langerhans cell histiocytosis. It is a benign lymphoproliferative disorder involving only skin and subcutaneous tissue, which is rare and not well documented.
Afthab Jameela Wahab   +2 more
doaj   +1 more source

Smoking-related interstitial lung disease [PDF]

open access: yes, 2011
Cigarette smoking has a clear epidemiological association with lung diseases, characterised by chronic inflammation of both the bronchiolar and the interstitial lung compartments.
CERRI, Stefania   +3 more
core   +1 more source

Indeterminate cell histocytosis with naïve cells

open access: yesRare Tumors, 2013
Histiocytoses are a heterogeneous group of disorders characterized by proliferation and accumulation of cells of mononuclearmacrophage system and dendritic cells.
Sheren F Younes   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy